600557 康缘药业
午间休市 07-16 11:29:59
资讯
新帖
简况
每周股票复盘：康缘药业（600557）51个产品纳入国家基药目录
证券之星 · 07-12
每周股票复盘：康缘药业（600557）51个产品纳入国家基药目录
股市必读：康缘药业（600557）7月8日董秘有最新回复
证券之星 · 07-09
股市必读：康缘药业（600557）7月8日董秘有最新回复
股市必读：康缘药业（600557）7月3日董秘有最新回复
证券之星 · 07-06
股市必读：康缘药业（600557）7月3日董秘有最新回复
每周股票复盘：康缘药业（600557）拟回购股份总额不低于1亿元
证券之星 · 07-05
每周股票复盘：康缘药业（600557）拟回购股份总额不低于1亿元
康缘药业（600557）披露以集中竞价交易方式回购公司股份的进展公告，7月3日股价上涨0.87%
证券之星 · 07-03
康缘药业（600557）披露以集中竞价交易方式回购公司股份的进展公告，7月3日股价上涨0.87%
康缘药业：截至6月30日公司尚未实施回购股份
证券日报网 · 07-03
康缘药业：截至6月30日公司尚未实施回购股份
康缘药业：ZX2021注射液、ZX2010注射液临床II期均已完成受试者入组
证券之星 · 07-03
康缘药业：ZX2021注射液、ZX2010注射液临床II期均已完成受试者入组
康缘药业：公司目前未持有GAP认证基地
证券之星 · 06-29
康缘药业：公司目前未持有GAP认证基地
6月29日康缘药业涨10.03%，方正富邦鑫诚12个月持有混合A基金重仓该股
证券之星 · 06-29
6月29日康缘药业涨10.03%，方正富邦鑫诚12个月持有混合A基金重仓该股
异动快报：康缘药业（600557）6月29日10点21分触及涨停板
证券之星 · 06-29
异动快报：康缘药业（600557）6月29日10点21分触及涨停板
每周股票复盘：康缘药业（600557）推1至2亿回购并注销股份
证券之星 · 06-28
每周股票复盘：康缘药业（600557）推1至2亿回购并注销股份
康缘药业(600557.SH)获得一贯煎颗粒药品注册证书
智通财经 · 06-26
康缘药业(600557.SH)获得一贯煎颗粒药品注册证书
康缘药业（600557）披露前十大股东持股情况，6月22日股价下跌1.94%
证券之星 · 06-22
康缘药业（600557）披露前十大股东持股情况，6月22日股价下跌1.94%
股市必读：康缘药业（600557）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：康缘药业（600557）6月1日董秘有最新回复
康缘药业：公司中药新药研发一直围绕病毒性感染、心脑血管、妇科、骨伤科、消化/肾病等优势领域
证券之星 · 06-01
康缘药业：公司中药新药研发一直围绕病毒性感染、心脑血管、妇科、骨伤科、消化/肾病等优势领域
康缘药业：公司在化药和生物药领域，已储备多个研发管线
证券之星 · 06-01
康缘药业：公司在化药和生物药领域，已储备多个研发管线
康缘药业：热毒宁注射液被列入《中医药治疗埃博拉出血热专家指导意见》
证券之星 · 05-29
康缘药业：热毒宁注射液被列入《中医药治疗埃博拉出血热专家指导意见》
股市必读：康缘药业(600557)股东户数4.22万户，较上期减少1.33%
证券之星 · 05-06
股市必读：康缘药业(600557)股东户数4.22万户，较上期减少1.33%
每周股票复盘：康缘药业（600557）Q1营收净利双降
证券之星 · 05-02
每周股票复盘：康缘药业（600557）Q1营收净利双降
康缘药业（600557）披露2026年第一季度报告，4月29日股价上涨0.14%
证券之星 · 04-29
康缘药业（600557）披露2026年第一季度报告，4月29日股价上涨0.14%
加载更多
公司概况
公司名称：
江苏康缘药业股份有限公司
所属行业：
医药制造业
上市日期：
2002-09-18
主营业务：
江苏康缘药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是注射类产品、口服类产品、外用类产品。公司是国家技术创新示范企业、国家重点高新技术企业、国家创新型试点企业、国家知识产权示范企业，全国制药工业百强企业。
发行价格：
7.00
{"stockData":{"symbol":"600557","market":"SH","secType":"STK","nameCN":"康缘药业","latestPrice":13.48,"timestamp":1784172599000,"preClose":13.28,"halted":0,"volume":11485285,"delay":0,"changeRate":0.0151,"floatShares":566000000,"shares":566000000,"eps":0.5296,"marketStatus":"午间休市","change":0.2,"latestTime":"07-16 11:29:59","open":13.03,"high":13.54,"low":12.95,"amount":153000000,"amplitude":0.0444,"askPrice":13.48,"askSize":34,"bidPrice":13.47,"bidSize":68,"shortable":0,"etf":0,"ttmEps":0.5296,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784178000000},"marketStatusCode":3,"adr":0,"adjPreClose":13.28,"symbolType":"stock","openAndCloseTimeList":[[1784165400000,1784172600000],[1784178000000,1784185200000]],"highLimit":14.61,"lowLimit":11.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":566158806,"isCdr":false,"pbRate":1.54,"roa":"--","peRate":25.453172,"roe":"1.63%","epsLYR":0.54,"committee":-0.606943,"marketValue":7632000000,"turnoverRate":0.0203,"status":0,"floatMarketCap":7632000000},"requestUrl":"/m/hq/s/600557","defaultTab":"news","newsList":[{"id":"2650154911","title":"每周股票复盘：康缘药业（600557）51个产品纳入国家基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154911","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650154911?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:35","pubTimestamp":1783794911,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，康缘药业报收于12.4元，较上周的12.72元下跌2.52%。本周，康缘药业7月6日盘中最高价报12.85元。本周关注点来自公司公告汇总：51个产品纳入《国家基本药物目录》，其中8个为新增纳入。江苏康缘药业股份有限公司共有51个产品纳入该目录，其中8个药品新增纳入，包括散结镇痛胶囊、清热解毒口服液、小柴胡颗粒、恩格列净片等，原43个品种继续保留，无产品退出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600557","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650891881","title":"股市必读：康缘药业（600557）7月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2650891881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650891881?lang=zh_cn&edition=full","pubTime":"2026-07-09 01:37","pubTimestamp":1783532229,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，康缘药业报收于12.5元，上涨4.25%，换手率2.29%，成交量12.94万手，成交额1.61亿元。董秘最新回复投资者： 董秘您好，我是一名税务专家，我注意到：贵公司过去五年加总的实际所得税率位于行业最低10%。税务问题的专业性强，复杂度高，对企业发展至关重要。当日关注点交易信息汇总：7月8日主力资金净流入631.47万元，游资资金净流入133.88万元，散户资金净流出765.36万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600557","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649843619","title":"股市必读：康缘药业（600557）7月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649843619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649843619?lang=zh_cn&edition=full","pubTime":"2026-07-06 03:20","pubTimestamp":1783279222,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康缘药业报收于12.72元，上涨0.87%，换手率1.72%，成交量9.76万手，成交额1.23亿元。公司公告汇总：康缘药业回购股份方案已获董事会及年度股东会审议通过，回购资金总额为1亿至2亿元、价格上限20.9元/股、期限至2027年6月25日；截至6月30日尚未实施回购。回购股份将用于减少注册资本，并在回购完成后予以注销。公司将根据市场情况择机实施回购，并按规定履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600001159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692342","title":"每周股票复盘：康缘药业（600557）拟回购股份总额不低于1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692342","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649692342?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:18","pubTimestamp":1783192693,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康缘药业报收于12.72元，较上周的10.87元上涨17.02%。本周，康缘药业7月3日盘中最高价报12.81元。本周关注点公司公告汇总：康缘药业拟以不低于1亿元且不超过2亿元资金回购股份，价格不超20.9元/股。公司公告汇总江苏康缘药业股份有限公司于2026年4月22日及6月26日召开董事会及年度股东会，审议通过以集中竞价交易方式回购公司股份的方案。截至2026年6月30日，公司尚未实施回购股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648617366","title":"康缘药业（600557）披露以集中竞价交易方式回购公司股份的进展公告，7月3日股价上涨0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648617366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648617366?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:39","pubTimestamp":1783089557,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康缘药业报收于12.72元，较前一交易日上涨0.87%，最新总市值为72.02亿元。近日，江苏康缘药业股份有限公司发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示，公司于2026年4月22日及6月26日召开董事会及年度股东会，审议通过以集中竞价交易方式回购公司股份的方案。回购股份将用于减少注册资本，并在回购完成后予以注销。截至2026年6月30日，公司尚未实施回购股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648177669","title":"康缘药业：截至6月30日公司尚未实施回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2648177669","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648177669?lang=zh_cn&edition=full","pubTime":"2026-07-03 20:32","pubTimestamp":1783081920,"startTime":"0","endTime":"0","summary":"证券日报网讯 7月3日，康缘药业发布公告称，截至2026年6月30日，公司尚未实施回购股份，公司后续将根据市场情况择机实施本次回购方案。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-03/doc-inifpuss2411223.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-03/doc-inifpuss2411223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0239","600557","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648020652","title":"康缘药业：ZX2021注射液、ZX2010注射液临床II期均已完成受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2648020652","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648020652?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:57","pubTimestamp":1783069055,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业(600557)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司的两种靶向生物减肥药的临床二期什么时候结束，实验的效果如何，三期何时展开？康缘药业回复：尊敬的投资者，您好！公司研发管线稳步推进中，生物创新药ZX2021注射液、ZX2010注射液目前临床II期均已完成受试者入组，计划在现有剂量安全性、可靠性良好的基础上进行更高剂量探索。对于上述药品临床试验进展、审评审批结果等关键信息，公司会按照相关法律法规的要求及时履行信息披露义务。感谢您对公司的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300030641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647207023","title":"康缘药业：公司目前未持有GAP认证基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2647207023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647207023?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:54","pubTimestamp":1782726885,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业(600557)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！公司现有通过GAP认证基地多少亩？康缘药业回复：尊敬的投资者，您好！公司主要业务涉及药品的研发、生产与销售，目前未持有GAP认证基地。公司构建规范、专业、高效的招标采购管理体系，确保相关药材源自符合国家GAP标准的规范化种植基地。同时，公司进一步优化生产质量管控体系，确保原料、中间体和成品批次间质量稳定、均一，从生产环节切实保障药品安全有效、稳定可控。谢谢！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600557","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647032419","title":"6月29日康缘药业涨10.03%，方正富邦鑫诚12个月持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647032419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647032419?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:29","pubTimestamp":1782721775,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日康缘药业涨10.03%创60日新低，收盘报11.96元，换手率1.64%，成交量9.27万手，成交额1.07亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为方正富邦基金的方正富邦鑫诚12个月持有混合A。方正富邦鑫诚12个月持有混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600557","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647342096","title":"异动快报：康缘药业（600557）6月29日10点21分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647342096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647342096?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:25","pubTimestamp":1782699930,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点21分康缘药业（600557）触及涨停板。其所属行业中药目前上涨。领涨股为太龙药业。该股为创新药，医药，阿尔茨海默病概念热股，当日创新药概念上涨5.33%，医药概念上涨3.5%，阿尔茨海默病概念上涨3.04%。6月26日的资金流向数据方面，主力资金净流出568.94万元，占总成交额9.63%，游资资金净流出137.44万元，占总成交额2.33%，散户资金净流入706.38万元，占总成交额11.95%。近5日资金流向一览见下表：康缘药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900008460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315802","title":"每周股票复盘：康缘药业（600557）推1至2亿回购并注销股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315802?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:06","pubTimestamp":1782587174,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，康缘药业报收于10.87元，较上周的11.83元下跌8.11%。本周，康缘药业6月23日盘中最高价报12.09元。江苏世纪同仁律师事务所确认，康缘药业2025年年度股东会的召集、召开程序、出席人员资格、表决程序及结果合法有效。康缘药业于2026年6月26日召开2025年年度股东会，出席会议股东及代理人共453人，代表有表决权股份256,490,723股，占总股本的45.3037%。回购股份将全部用于减少注册资本并注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646351617","title":"康缘药业(600557.SH)获得一贯煎颗粒药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2646351617","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646351617?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:05","pubTimestamp":1782471932,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康缘药业(600557.SH)发布公告，公司于近日收到国家药品监督管理局签发的一贯煎颗粒《药品注册证书》。功能主治：滋阴疏肝。用于肝阴不足，血燥气郁证。症见胸脘胁痛，吞酸吐苦，咽干口燥，舌红少津，脉细弦。亦治疝气瘕聚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600557","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073406","title":"康缘药业（600557）披露前十大股东持股情况，6月22日股价下跌1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645073406?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:38","pubTimestamp":1782139103,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，康缘药业报收于11.6元，较前一交易日下跌1.94%，最新总市值为65.67亿元。该股当日开盘11.78元，最高11.78元，最低11.29元，成交额达6179.17万元，换手率为0.95%。公告显示，截至2026年6月17日股东会股权登记日，公司前十大股东及前十大无限售条件股东的持股情况。其中，江苏康缘集团有限责任公司持股176,173,467股，占比31.12%，为第一大股东。连云港康贝尔医疗器械有限公司、肖伟等位列其后。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969870","title":"股市必读：康缘药业（600557）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640969870?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:09","pubTimestamp":1780337354,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，康缘药业报收于12.86元，下跌0.39%，换手率0.79%，成交量4.47万手，成交额5740.72万元。董秘最新回复投资者： 公司应当向同城的恒瑞和豪森学习，逐步收缩中药业务，向化学药和生物药倾斜，另外，请贵司说明，为什么中新医药合并报表后研发费用反而不见增加，是不是研发费用这一项目有什么会计上的特殊处理方法？现阶段中药业务仍然是公司主营业务和现金流，确保公司运营和研发投入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640958083","title":"康缘药业：公司中药新药研发一直围绕病毒性感染、心脑血管、妇科、骨伤科、消化/肾病等优势领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640958083?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:15","pubTimestamp":1780308920,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业06月01日在投资者关系平台上答复投资者关心的问题。强烈建议公司梳理中药研发管线，将一些中药不占优势，疗效不明显的非重点科室的项目中止。公司中药新药研发一直围绕病毒性感染、心脑血管、妇科、骨伤科、消化/肾病等优势领域，以十年为一个研发周期，合理布局管线，确保研发成果持续产出，为营销提供丰富产品组合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640958701","title":"康缘药业：公司在化药和生物药领域，已储备多个研发管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640958701?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:13","pubTimestamp":1780308802,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业06月01日在投资者关系平台上答复投资者关心的问题。公司在化药和生物药领域，已储备多个研发管线，覆盖多个治疗领域，构建中长期产品梯队，高起点的布局，确保未来创新药不断产出。现阶段中药业务仍然是公司主营业务和现金流，确保公司运营和研发投入。在收购中新医药后，公司生物药领域的研发投入有所加大。公司会结合行业趋势与自身实际，合理配置研发资源。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600557","BK0188","159839","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639862921","title":"康缘药业：热毒宁注射液被列入《中医药治疗埃博拉出血热专家指导意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2639862921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639862921?lang=zh_cn&edition=full","pubTime":"2026-05-29 18:24","pubTimestamp":1780050280,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业(600557)05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：康缘药业有没有治疗或缓解埃博拉的药？热毒宁注射液是不是列入《中医药治疗埃博拉出血热专家指导意见》？康缘药业回复：尊敬的投资者，您好！热毒宁注射液被列入2014年由国家中医药管理局办公室印发的《中医药治疗埃博拉出血热专家指导意见（第一版）》，该文件属于中医药治疗埃博拉出血热的指导性意见，目前公司暂无专门用于治疗或缓解埃博拉病毒的药物。谢谢！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900035445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633920984","title":"股市必读：康缘药业(600557)股东户数4.22万户，较上期减少1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633920984","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633920984?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:46","pubTimestamp":1778017573,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，康缘药业报收于13.48元，下跌3.37%，换手率1.96%，成交量11.08万手，成交额1.5亿元。来自股本股东变化：截至2026年3月31日，公司股东户数环比下降1.33%，户均持股数量上升至1.34万股。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为4.22万户，较2025年12月31日减少568.0户，减幅为1.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600557","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632234666","title":"每周股票复盘：康缘药业（600557）Q1营收净利双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2632234666","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632234666?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:18","pubTimestamp":1777673892,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，康缘药业报收于13.48元，较上周的14.21元下跌5.14%。本周关注点来自业绩披露要点：康缘药业2026年一季报显示，一季度主营收入8.31亿元，同比下降5.27%；归母净利润7927.59万元，同比下降4.96%。股本股东变化股东户数变动截至2026年3月31日，康缘药业股东户数为4.22万户，较2025年12月31日减少568户，减幅1.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631554368","title":"康缘药业（600557）披露2026年第一季度报告，4月29日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631554368","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631554368?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:27","pubTimestamp":1777472858,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，康缘药业报收于13.95元，较前一交易日上涨0.14%，最新总市值为78.98亿元。该股当日开盘13.91元，最高14.06元，最低13.87元，成交额达6202.29万元，换手率为0.78%。近日，江苏康缘药业股份有限公司披露《2026年第一季度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900069325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784173322671,"stockEarnings":[{"period":"1week","weight":0.0624},{"period":"1month","weight":0.0939},{"period":"3month","weight":-0.0528},{"period":"6month","weight":-0.1111},{"period":"1year","weight":-0.1476},{"period":"ytd","weight":-0.0588}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0345},{"period":"3month","weight":-0.0246},{"period":"6month","weight":-0.0357},{"period":"1year","weight":0.1286},{"period":"ytd","weight":-0.0033}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康缘药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42174人(较上一季度减少1.33%)","perCapita":"13424股","listingDate":"2002-09-18","address":"江苏省连云港市连云区经济技术开发区江宁工业城","registeredCapital":"56615万元","survey":" 江苏康缘药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是注射类产品、口服类产品、外用类产品。公司是国家技术创新示范企业、国家重点高新技术企业、国家创新型试点企业、国家知识产权示范企业，全国制药工业百强企业。","listedPrice":7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康缘药业(600557)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康缘药业(600557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康缘药业,600557,康缘药业股票,康缘药业股票老虎,康缘药业股票老虎国际,康缘药业行情,康缘药业股票行情,康缘药业股价,康缘药业股市,康缘药业股票价格,康缘药业股票交易,康缘药业股票购买,康缘药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康缘药业(600557)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康缘药业(600557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}